Clearside Biomedical Inc (CLSD) — Cash Flow Reinvestment Rate
Latest as of December 2023:
0.48x
Clearside Biomedical Inc (CLSD) has a Cash Flow Reinvestment Rate of 0.48x as of December 2023, reinvesting $240.00K (capex $120.00K plus investments $-120.00K) from operating cash flow of $495.00K. Explore CLSD capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.48x
(Capex + Investments) / Operating CF
Total Reinvested
$240.00K
Capex + Investments
Operating Cash Flow
$495.00K
USD
Capital Expenditures
$120.00K
USD
Annual Cash Flow Reinvestment Rate for Clearside Biomedical Inc (None–None)
Year-by-year capital reinvestment analysis for Clearside Biomedical Inc. For live market cap and broader valuation context, see CLSD stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow